Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial.

Rizas KD, Mourouzis K, Rath D, Olivier CB, Villegas Sierra LE, Korovesis T, Polzin A, Tawil AA, Wakili R, von Stuelpnagel L, Mayer K, Janisch M, Ulrich T, Lang S, Maier SKG, Brattinger F, Bott-Flügel L, Bogossian H, Iliodromitis K, Freyer L, Steffen J, Stark K, Eiffener E, Sams LE, Petzold T, Linke A, Heidrich FM, Sossala S, Zako S, Dagkonakis N, Schäfer A, Edelmann F, Leistner DM, Maslarska M, Knebel F, Nickenig G, Luani B, Rassaf T, Ince H, Akin I, Maeder MT, Gawaz M, Feistritzer HJ, Frey N, Kääb S, Sahin R, Pauschinger M, Stiermaier T, Eitel I, Kollum M, Wolter JS, Schreinlechner M, Bauer A, Stellbrink C, Landmesser U, Kirchhof P, Sibbing D, Thiele H, Kastrati A, Mansmann U, Massberg S

Open source

DOI: 10.1038/s41591-026-04629-7
Published: 2026 Aug 29
Container: Nature medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41591-026-04629-7,
  title = {Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial.},
  author = {Rizas KD and Mourouzis K and Rath D and Olivier CB and Villegas Sierra LE and Korovesis T and Polzin A and Tawil AA and Wakili R and von Stuelpnagel L and Mayer K and Janisch M and Ulrich T and Lang S and Maier SKG and Brattinger F and Bott-Flügel L and Bogossian H and Iliodromitis K and Freyer L and Steffen J and Stark K and Eiffener E and Sams LE and Petzold T and Linke A and Heidrich FM and Sossala S and Zako S and Dagkonakis N and Schäfer A and Edelmann F and Leistner DM and Maslarska M and Knebel F and Nickenig G and Luani B and Rassaf T and Ince H and Akin I and Maeder MT and Gawaz M and Feistritzer HJ and Frey N and Kääb S and Sahin R and Pauschinger M and Stiermaier T and Eitel I and Kollum M and Wolter JS and Schreinlechner M and Bauer A and Stellbrink C and Landmesser U and Kirchhof P and Sibbing D and Thiele H and Kastrati A and Mansmann U and Massberg S},
  year = {2026},
  journal = {Nature medicine},
  doi = {10.1038/s41591-026-04629-7},
  url = {https://doi.org/10.1038/s41591-026-04629-7}
}

RIS

TY  - JOUR
TI  - Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial.
AU  - Rizas KD
AU  - Mourouzis K
AU  - Rath D
AU  - Olivier CB
AU  - Villegas Sierra LE
AU  - Korovesis T
AU  - Polzin A
AU  - Tawil AA
AU  - Wakili R
AU  - von Stuelpnagel L
AU  - Mayer K
AU  - Janisch M
AU  - Ulrich T
AU  - Lang S
AU  - Maier SKG
AU  - Brattinger F
AU  - Bott-Flügel L
AU  - Bogossian H
AU  - Iliodromitis K
AU  - Freyer L
AU  - Steffen J
AU  - Stark K
AU  - Eiffener E
AU  - Sams LE
AU  - Petzold T
AU  - Linke A
AU  - Heidrich FM
AU  - Sossala S
AU  - Zako S
AU  - Dagkonakis N
AU  - Schäfer A
AU  - Edelmann F
AU  - Leistner DM
AU  - Maslarska M
AU  - Knebel F
AU  - Nickenig G
AU  - Luani B
AU  - Rassaf T
AU  - Ince H
AU  - Akin I
AU  - Maeder MT
AU  - Gawaz M
AU  - Feistritzer HJ
AU  - Frey N
AU  - Kääb S
AU  - Sahin R
AU  - Pauschinger M
AU  - Stiermaier T
AU  - Eitel I
AU  - Kollum M
AU  - Wolter JS
AU  - Schreinlechner M
AU  - Bauer A
AU  - Stellbrink C
AU  - Landmesser U
AU  - Kirchhof P
AU  - Sibbing D
AU  - Thiele H
AU  - Kastrati A
AU  - Mansmann U
AU  - Massberg S
PY  - 2026
JO  - Nature medicine
DO  - 10.1038/s41591-026-04629-7
UR  - https://doi.org/10.1038/s41591-026-04629-7
ER  -

APA

KD, R., K, M., D, R., CB, O., LE, V. S., T, K., A, P., AA, T., R, W., L, V. S., K, M., M, J., T, U., S, L., SKG, M., F, B., L, B., H, B., K, I., L, F., J, S., K, S., E, E., LE, S., T, P., A, L., FM, H., S, S., S, Z., N, D., A, S., F, E., DM, L., M, M., F, K., G, N., B, L., T, R., H, I., I, A., MT, M., M, G., HJ, F., N, F., S, K., R, S., M, P., T, S., I, E., M, K., JS, W., M, S., A, B., C, S., U, L., P, K., D, S., H, T., A, K., U, M., & S, M. (2026). Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial.. Nature medicine. https://doi.org/10.1038/s41591-026-04629-7

Source records

pubmed · retrieved 2026-09-25T17:28:54.784Z